Robert Lisicki is CCO & VP at ARENA PHARMACEUTICALS INC (ARNA). They have made 5 open-market trades across 1 company since 2019, most recently 2022-03-11.
CIK 0001779614
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARNA | 21,462 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2022-03-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARNA | SELL | 2021-08-03 | 2021-08-05 | $60.03 | $1.4M | -22.6% | -3.6% | +2.2% |
| ARNA | SELL | 2021-02-02 | 2021-02-04 | $78.96 | $2.3M | +1.0% | -11.7% | -20.5% |
| ARNA | SELL | 2020-12-01 | 2020-12-03 | $66.06 | $455K | +9.4% | +15.7% | +12.5% |
| ARNA | SELL | 2020-08-04 | 2020-08-06 | $63.34 | $3.8M | +2.9% | +0.3% | +35.5% |
| ARNA | SELL | 2019-11-13 | 2019-11-26 | $45.83 | $406K | +0.7% | -3.8% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.